These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 30028902)

  • 1. Altered bone-regulating myokine expression in skeletal muscle Of Duchenne muscular dystrophy mouse models.
    Zhou S; Qian B; Wang L; Zhang C; Hogan MV; Li H
    Muscle Nerve; 2018 Oct; 58(4):573-582. PubMed ID: 30028902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Expression of FGF-21 Negatively Affects Bone Homeostasis in Dystrophin/Utrophin Double Knockout Mice.
    Li H; Sun H; Qian B; Feng W; Carney D; Miller J; Hogan MV; Wang L
    J Bone Miner Res; 2020 Apr; 35(4):738-752. PubMed ID: 31800971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of qPCR Reference Genes Suitable for Normalizing Gene Expression in a Canine Model of Duchenne Muscular Dystrophy.
    Hildyard JCW; Taylor-Brown F; Massey C; Wells DJ; Piercy RJ
    J Neuromuscul Dis; 2018; 5(2):177-191. PubMed ID: 29614692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning of cDNA encoding a regeneration-associated muscle protease whose expression is attenuated in cell lines derived from Duchenne muscular dystrophy patients.
    Nakayama Y; Nara N; Kawakita Y; Takeshima Y; Arakawa M; Katoh M; Morita S; Iwatsuki K; Tanaka K; Okamoto S; Kitamura T; Seki N; Matsuda R; Matsuo M; Saito K; Hara T
    Am J Pathol; 2004 May; 164(5):1773-82. PubMed ID: 15111323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Muscle-Bone Unit: Filling Two Needs with One Deed in the Treatment of Duchenne Muscular Dystrophy.
    Boulanger Piette A; Hamoudi D; Marcadet L; Morin F; Argaw A; Ward L; Frenette J
    Curr Osteoporos Rep; 2018 Oct; 16(5):541-553. PubMed ID: 30225627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new therapeutic effect of fenofibrate in Duchenne muscular dystrophy: The promotion of myostatin degradation.
    Sun Z; Xu D; Zhao L; Li X; Li S; Huang X; Li C; Sun L; Liu B; Jiang Z; Zhang L
    Br J Pharmacol; 2022 Mar; 179(6):1237-1250. PubMed ID: 34553378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
    Montgomery E; Pennington C; Isales CM; Hamrick MW
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of genes involved in the calcium homeostasis in masticatory muscles of MDX mice.
    Kunert-Keil CH; Gredes T; Lucke S; Botzenhart U; Dominiak M; Gedrange T
    J Physiol Pharmacol; 2014 Apr; 65(2):317-24. PubMed ID: 24781740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Latent TGFβ Binding Protein 4 in Muscle Ameliorates Muscular Dystrophy through Myostatin and TGFβ.
    Lamar KM; Bogdanovich S; Gardner BB; Gao QQ; Miller T; Earley JU; Hadhazy M; Vo AH; Wren L; Molkentin JD; McNally EM
    PLoS Genet; 2016 May; 12(5):e1006019. PubMed ID: 27148972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle secretome in Duchenne muscular dystrophy: a pivotal anti-inflammatory role of adiponectin.
    Lecompte S; Abou-Samra M; Boursereau R; Noel L; Brichard SM
    Cell Mol Life Sci; 2017 Jul; 74(13):2487-2501. PubMed ID: 28188344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
    J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent PTH treatment improves bone and muscle in glucocorticoid treated Mdx mice: A model of Duchenne Muscular Dystrophy.
    Yoon SH; Grynpas M; Mitchell J
    Bone; 2019 Apr; 121():232-242. PubMed ID: 30716510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the bone and growth phenotype of
    Wood CL; Suchacki KJ; van 't Hof R; Cawthorn WP; Dillon S; Straub V; Wong SC; Ahmed SF; Farquharson C
    Dis Model Mech; 2020 Jan; 13(2):. PubMed ID: 31754018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Altered expression of myostatin gene in the progressive muscular dystrophy patients].
    Zhang Y; Chen Y; Chen JW; Zhu DH
    Yi Chuan Xue Bao; 2005 Aug; 32(8):779-83. PubMed ID: 16231730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localized expression of specific P2X receptors in dystrophin-deficient DMD and mdx muscle.
    Jiang T; Yeung D; Lien CF; Górecki DC
    Neuromuscul Disord; 2005 Mar; 15(3):225-36. PubMed ID: 15725584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression in mdx mouse muscle in relation to age and exercise: aberrant mechanical-metabolic coupling and implications for pre-clinical studies in Duchenne muscular dystrophy.
    Camerino GM; Cannone M; Giustino A; Massari AM; Capogrosso RF; Cozzoli A; De Luca A
    Hum Mol Genet; 2014 Nov; 23(21):5720-32. PubMed ID: 24916377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemojuvelin is a novel suppressor for Duchenne muscular dystrophy and age-related muscle wasting.
    Zhang P; He J; Wang F; Gong J; Wang L; Wu Q; Li W; Liu H; Wang J; Zhang K; Li M; Huang X; Pu C; Li Y; Jiang F; Wang F; Min J; Chen X
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):557-573. PubMed ID: 30884219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference with myostatin/ActRIIB signaling as a therapeutic strategy for Duchenne muscular dystrophy.
    Amthor H; Hoogaars WM
    Curr Gene Ther; 2012 Jun; 12(3):245-59. PubMed ID: 22554312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys.
    St Andre M; Johnson M; Bansal PN; Wellen J; Robertson A; Opsahl A; Burch PM; Bialek P; Morris C; Owens J
    Skelet Muscle; 2017 Nov; 7(1):25. PubMed ID: 29121992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.